NCT00453609View on ClinicalTrials.gov

Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI)

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
SchizophreniaSchizoaffective DisorderBipolar DisorderAlcohol Dependence
Interventions
DRUG

long-lasting injectable naltrexone

Trial Locations (3)

13203

St. Joseph's Mental Health Services, Syracuse

13210

Hutchings Psychiatric Center, Syracuse

SUNY Upstate Medical University, Syracuse

All Listed Sponsors
lead

State University of New York - Upstate Medical University

OTHER

NCT00453609 - Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI) | Biotech Hunter | Biotech Hunter